Overcoming drug resistance and stemness in oncogenic kras driven pancreatic ductal adenocarcinoma through PAK4 inhibition

被引:0
|
作者
Azmi, Asfar S. [1 ]
Senapedis, William [2 ]
Baloglu, Erkan [2 ]
Landesman, Yosef [2 ]
Kauffman, Michael [2 ]
Shacham, Sharon [2 ]
Wu, Jack [1 ]
Aboukameel, Amro [1 ]
Muqbil, Irfana [1 ]
Mohammad, Ramzi M. [1 ,3 ]
机构
[1] Wayne State Univ, Detroit, MI USA
[2] Karyopharm Therapeut, Newton, MA USA
[3] iTRI HMC, Doha, Qatar
关键词
D O I
10.1158/1538-7445.AM2015-4688
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4688
引用
收藏
页数:2
相关论文
共 21 条
  • [21] Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer
    Hashimoto, Ari
    Handa, Haruka
    Hata, Soichiro
    Tsutaho, Akio
    Yoshida, Takao
    Hirano, Satoshi
    Hashimoto, Shigeru
    Sabe, Hisataka
    CELL COMMUNICATION AND SIGNALING, 2021, 19 (01)